Evaluation of Liver Masses and Accompanying Findings by Diffusion-Weighted Magnetic Resonance Imaging


Abstract views: 80 / PDF downloads: 58

Authors

DOI:

https://doi.org/10.54614/eurjther.2021.0107

Keywords:

Hepatic masses, diffusion-weighted imaging, magnetic resonance imaging, cyst hydatid, hepatic hemangioma

Abstract

Objective:The aim of this study was to investigate the contribution of diffusion-weighted magnetic resonance imaging to differential diagnosis in the characterization of liver masses.

Methods: Diffusion-weighted sequences were added to conventional sequences in cases in which a mass was detected during upper abdominal magnetic resonance imaging performed for any reason. Diffusion-weighted images were obtained by applying diffusion-sensitive gradients at the b0, b600, and b1000 values with a single shot echo-planar spin echo sequence in the axial plane using the 1.5T magnetic resonance imaging device, and apparent diffusion coefficient maps were automatically constructed from these images by the magnetic resonance imaging device. The mean apparent diffusion coefficient values were calculated for 56 masses and 45 liver parenchyma in 45 cases with histopathological diagnoses.

Results: Of the 56 masses, 28 were benign and 28 were malignant. The benign masses consisted of 11 hemangiomas, 8 hydatid cysts, 3 simple cysts, 4 abscesses, and 2 focal nodular hyperplasia. The malignant masses comprised 13 hepatocellular carcinomas, 12 metastases, 2 cholangio cellular carcinomas, and 1 carcinosarcoma. The mean apparent diffusion coefficient value of the benign masses was calculated to be 2.67 × 10−3 s/mm2 and that of the apparent diffusion coefficient value was 1.21 × 10−3 s/mm2 , indicating a statistically significant difference between the 2 groups. Apparent diffusion coefficient combined with diffusion-weighted magnetic resonance imaging had 100% sensitivity and 69% specificity in the differentiation of benign and malignant masses

Conclusion: Diffusion-weighted magnetic resonance imaging is a technique that provides results in a short time without using any contrast agent and contributes to the differential diagnosis of liver masses and should be added to conventional sequences.

Metrics

Metrics Loading ...

References

Fujita N, Nishie A, Asayama Y, et al. Hyperintense Liver Masses at hepatobiliary Phase gadoxetic acid-enhanced MRI: imaging Appearances and Clinical Importance. RadioGraphics. 2020;40(1):72-94.

Tello R, Fenlon HM, Gagliano T, deCarvalho VL, Yucel EK. Prediction rule for characterization of hepatic lesions revealed on MR imaging: estimation of malignancy. AJR Am J Roentgenol. 2001;176(4):879-884.

de Figueiredo EH, Borgonovi AF, Doring TM. Basic concepts of MR imaging, diffusion MR imaging, and diffusion tensor imaging. Magn Reson Imaging Clin N Am. 2011;19(1):1-22.

Oyar O, Gülsoy UK. Tıbbi Görüntüleme Fiziği. Suleyman Demirel Universitesi Tıp Fakultesi, 2003;1:281-366.

Federau C, Maeder P, O'Brien K, Browaeys P, Meuli R, Hagmann P. Quantitative measurement of brain perfusion with intravoxel incoherent motion MR imaging. Radiology. 2012;265(3):874-881.

Chen ZG, Xu L, Zhang SW, Huang Y, Pan RH. Lesion discrimination with breath-hold hepatic diffusion-weighted imaging: a meta-analysis. World J Gastroenterol. 2015;21(5):1621-1627.

Miller FH, Hammond N, Siddiqi AJ, et al. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions. J Magn Reson Imaging. 2010;32(1):138-147.

Lewis S, Dyvorne H, Cui Y, Taouli B. Diffusion-weighted imaging of the liver: techniques and applications. Magn Reson Imaging Clin N Am. 2014;22(3):373-395.

Tosun M, Inan N, Sarisoy HT, et al. Diagnostic performance of conventional diffusion weighted imaging and diffusion tensor imaging for the liver fibrosis and inflammation. Eur J Radiol. 2013;82(2):203-207.

Testa ML, Chojniak R, Sene LS, et al. Is DWI/ADC a useful tool in the characterization of focal hepatic lesions suspected of malignancy? PLOS ONE. 2014;9(7):e101944.

Koh DM, Collins DJ. Diffusion-weighted MR imaging in the body: applications and challenceges in oncology. AJR Am J Roentgenol. 2007;188(6):1622-1635.

Galea N, Cantisani V, Taouli B. Liver lesion detection and characterization: role of diffusion-weighted imaging. J Magn Reson Imaging. 2013;37(6):1260-1276.

Bonekamp S, Corona-Villalobos CP, Kamel IR. Oncologic applications of diffusion-weighted MRI in the body. J Magn Reson Imaging. 2012;35(2):257-279.

Wei C, Tan J, Xu L, et al. Differential diagnosis between hepatic metastases and benign focal lesions using DWI with parallel acquisition technique: a meta-analysis. Tumour Biol. 2015;36(2):983-990.

Inan N, Arslan A, Akansel G, et al. Diffusion-weighted imaging in the differential diagnosis of simple and hydatid cysts of the liver. AJR Am J Roentgenol. 2007;189(5):1031-1036.

Chan JH, Tsui EY, Luk SH, et al. Diffusion-weighted MR imaging of the liver: distinguishing hepatic abscess from cystic or necrotic tumor. Abdom Imaging. 2001;26(2):161-165.

Bruegel M, Rummeny EJ. Hepatic metastases use of diffusionweighted echo- planar imaging. Abdom Imaging. 2010;35(4);:454- 461.

Downloads

Published

2022-06-21

How to Cite

Özgül Gümüş, Ümmü G., & Karahan, Ökkeş İbrahim. (2022). Evaluation of Liver Masses and Accompanying Findings by Diffusion-Weighted Magnetic Resonance Imaging. European Journal of Therapeutics, 28(2), 89–95. https://doi.org/10.54614/eurjther.2021.0107

Issue

Section

Original Articles